Cargando…
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute manifestations of COVID-19 (long COVID-19) is understudied. Endothelial cells are sentinels lining the innermost layer of blood vessel that gatek...
Autores principales: | Xu, Suo-wen, Ilyas, Iqra, Weng, Jian-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574180/ https://www.ncbi.nlm.nih.gov/pubmed/36253560 http://dx.doi.org/10.1038/s41401-022-00998-0 |
Ejemplares similares
-
Vascular homeostasis in atherosclerosis: A holistic overview
por: Xu, Suowen, et al.
Publicado: (2022) -
Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
por: Chen, Kun, et al.
Publicado: (2023) -
Role of Polyphenols and Carotenoids in Endothelial Dysfunction: An Overview from Classic to Innovative Biomarkers
por: Di Pietro, Natalia, et al.
Publicado: (2020) -
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction
por: Xu, Suowen, et al.
Publicado: (2021) -
Endothelial Microparticles as Potential Biomarkers in the Assessment of Endothelial Dysfunction in Hypercholesterolemia
por: Nik Ibrahim, Nik Nor Izah, et al.
Publicado: (2022)